From: Proceedings of Réanimation 2020, the French Intensive Care Society International Congress
Overall population, n = 35 | Non survivors, n = 11 | Survivors, n = 24 | p | |
---|---|---|---|---|
Age–year | 48 [39–60] | 59 [41–65] | 27 [39–53] | 0.21 |
Known non ischemic cardiomyopathy | 14 (40) | 9 (81.8) | 5 (20.8) | 0.002 |
Known paroxystic atrial fibrillation | 10 (28.6) | 6 (54.5) | 4 (16.7) | 0.04 |
Type of supraventricular arrythmia—no. (%) | ||||
Atrial fibrillation | 27 (77.1) | 8 (72.7) | 19 (79.2) | 0.69 |
Atrial flutter | 3 (8.6) | 2 (18.2) | 1 (4.2) | 0.23 |
Atrial tachycardia | 2 (5.7) | 0 | 2 (8.3) | 0.99 |
Junctional tachycardia | 3 (8.6) | 1 (9.1) | 2 (3) | 0.99 |
Successful sustained reduction after amiodarone load and/or electric shock | 12 (34.3) | 1 (9.1) | 11 (45.8) | 0.003 |
SOFA score | 10 [7–13] | 12 [8–14] | 10 [7–12] | 0.29 |
Mechanical ventilation—no. (%) | 30 (85.7) | 10 (90.9) | 20 (83.3) | 0.99 |
Renal replacement therapy—no. (%) | 15 (42.9) | 9 (81.8) | 6 (25) | 0.003 |
Inotrope Score | 29 [11–80] | 67 [11–173] | 20 [12–63] | 0.29 |
Heart Rate before ECMO—beats/min | 150 [140–168] | 140 [120–150] | 158 [140–175] | 0.01 |
Lactate—mmol/L | 7.9 [4.3–11.3] | 7.2 [4.1–10.5] | 8 [4.3–11.4] | 0.61 |
NT Pro BNP—pg/mL | 8503 [3283–16,899] | 20,019 [14,250–34,534] | 4741 [2521–8503] | 0.0005 |
Left ventricular ejection fraction—% | 10 [10–15] | 10 [10–15] | 10 [10–15] | 0.83 |
ECMO duration | 11 [7–17] | 11 [5–12] | 12 [8–18] | 0.29 |
Recovery | 20 (57) | 2 (18.2) | 18 (75) | 0.003 |
Bridge to LVAD | 2 (5.7) | 0 | 2 | 0.99 |
Bridge to transplantation | 4 (11.4) | 0 | 4 | 0.28 |